alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Heidi L. Wagner Esq.
Senior Vice President of Global Government Affairs,Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Ms. Heidi L. Wagner, Esq. serves as Senior Vice President of Global Government Affairs at Alexion Pharmaceuticals, Inc. Ms. Wagner served as Vice President of Global Government Affairs of Alexion Pharmaceuticals, Inc. Ms. Wagner is an attorney with more than 20 years of experience in health care legislative and regulatory policy issues. Prior to joining Alexion Pharmaceuticals, Inc. in 2009, Ms. Wagner served as Senior Director of Government Affairs for Genentech, and ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*There is no Board Members Memberships data available.
University of Colorado–Boulder
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Stephen Edward Foots||Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee|
Croda International plc
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Chief Executive Officer, Managing Director, Member of the Management Council, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2014.|